Rosuvastatin lactone

CAS No. 503610-43-3

Rosuvastatin lactone( —— )

Catalog No. M36275 CAS No. 503610-43-3

Rosuvastatin lactone is the lactone form of the HMG-CoA reductase inhibitor rosuvastatin. It is found in vivo following rosuvastatin administration.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 147 Get Quote
10MG 259 Get Quote
25MG 518 Get Quote
50MG 759 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Rosuvastatin lactone
  • Note
    Research use only, not for human use.
  • Brief Description
    Rosuvastatin lactone is the lactone form of the HMG-CoA reductase inhibitor rosuvastatin. It is found in vivo following rosuvastatin administration.
  • Description
    Rosuvastatin lactone is a metabolite of Rosuvastatin (HY-17504A) (HMG-CoA inhibitor).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    503610-43-3
  • Formula Weight
    463.52
  • Molecular Formula
    C22H26FN3O5S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC(C)c1nc(nc(-c2ccc(F)cc2)c1\C=C\[C@@H]1C[C@@H](O)CC(=O)O1)N(C)S(C)(=O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Lee HB, et al. Occurrence and fate of rosuvastatin, rosuvastatin lactone, and atorvastatin in Canadian sewage and surface water samples. Chemosphere. 2009 Nov;77(10):1285-91.?
molnova catalog
related products
  • Xanthosine dihydrate

    Xanthosine is produced by guanine-free mutants of bacteria e.g. Bacillus subtilis Aerobacter aerogenes. Xanthosine monophosphate is an intermediate in purine metabolism formed from IMP and forming GMP.

  • Mc-Val-Cit-PAB-Cl

    Mc-Val-Cit-PAB-Cl can be used to conjugate MMAE and antibody to form antibody-MC-vc-MMAE.

  • CP-316819

    CP-316819 (GPi 819) is a potent inhibitor of glycogen phosphorylase (GPase) with hypoglycemic effects, inhibits huSMGPa and huLGPa, maintains neuronal activity during hypoglycemia, and can be used in the study of hyperglycemia.